Is It Time to Be Bullish on Amarin Corporation (AMRN)?

Amarin Corporation PLC (NASDAQ:AMRN) now has FDA approval for its triglyceride drug, Vascepa, and it is ready to take it to market early in 2013.

Keep Reading →